SanMelix develops advanced homeopathic compositions efficient in the treatment of a variety of wound and dermal afflictions.
SanMelix Laboratories has raised $135K in total funding. The most recent round was Equity Crowdfunding. The last funding was announced in January 2022.
SanMelix Laboratories's investors include Newchip Accelerator.
SanMelix Laboratories is headquartered in Hollywood, United States.
SanMelix develops advanced homeopathic compositions efficient in the treatment of a variety of wound and dermal afflictions.
SanMelix Laboratories is at the Equity Crowdfunding stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SanMelix Laboratories — Funding & Investors." VCBacked, January 12, 2022, https://www.vcbacked.co/company/sanmelix-laboratories. Accessed September 30, 2026.
VCBacked. (2022). SanMelix Laboratories — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/sanmelix-laboratories
{{cite web |title=SanMelix Laboratories — Funding & Investors |url=https://www.vcbacked.co/company/sanmelix-laboratories |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated